“Patient access to health information—whether it resides in a medical record, a lab company’s system, or an insurance company records—is a right firmly protected by federal laws and regulations,” writes Robert A. Dowling, MD.
“We found that female patients, Black patients, and patients with non-private insurance had a decreased odds of receiving opioids,” says Hailey Frye.
“A key point is the supply chain is very fragile, and there’s not really a good financial incentive to make these drugs,” says Ruchika Talwar,…
Panelists discuss how the evolving treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) encompasses multiple therapeutic options including novel hormonal agents, chemotherapy, and targeted therapies…
“Personally, I think monitoring and analyzing PSA kinetics is a great one because it’s cheap and it’s readily available,” says Dr Louise Kostos.
The study will evaluate the investigational drug product ONC175 (orellanine) in patients with metastatic clear cell or papillary renal cell carcinoma.
The trial is assessing the safety and tolerability of adaptive radiation therapy with concurrent sacituzumab govitecan in patients with MIBC.
“The study suggests that exercise would be an effective intervention for men with prostate cancer who express concern about sexual dysfunction, and that exercise medicine…
“4 years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who…
“Ultimately, there is no ‘right choice’ when it comes to urinary diversion,” writes Anne K. Schuckman, MD.
The overall prevalence of kidney stones overall remained stable, with a notable increase observed among women.
